Cancer Immunotherapy With Immunomodulatory Anti-Cd137 and Anti-Pd-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-15-0510

Related search